FATRIXGEL: universal biomaterial for 3D cell cultures
Project fact sheet
FATRIXGEL
Vertical: Customised health
Project description
The biomaterials used in researching new therapies, and regenerative and customised medicine, do not manage to recreate the micro-environments of native tissues.
For example, the drugs that work in vitro do not function in the following phase as the models do not include the necessary cell or enzymatic mechanisms.
Fatrixgel is a biomaterial that mimics the extracellular matrix of the native fabrics and, therefore, improves the efficiency of the 3D cell cultures.
This is achieved by means of a new patented tissue decellularization process that is fast, cost-effective, scalable and reproducible. Fatrixgel allows its properties to be adapted; always uses a single material; and can be used for any 3D culture protocol and process.
Tagline: Universal biomaterial for 3D cell cultures: Researching new customised therapies/medicine.
Financing needs:
Phase 1: €350,000 to set up company, CEO, commercial action, marketing, raw materials. Tecnalia manufactures the products.
Phase 2: €300,000-600,000 equipment for own manufacturing and scaling of sales internationally.
Market
Within the global 3D culture market (CAGR 15%, $6.5 billion in 2032), the target market is the scaffold-based segment, which accounted for 68% of the total in 2023.
The growth is driven by less use of animals, customised medicine and investment in R&D. The main customers are research institutes, biotechnological and pharmaceutical companies.
Technology tags
Business model
Project needs
Promoted by
Are you interested in high-tech projects capable of generating greater market impact?
Fill in this form and we will contact you if you want to take part in this initiative – either by contributing technology assets or if you are a talent promoter capable of turning them into business projects.
Related news
Prospect Biotech: real-time analysis of cell cultures using light
Basque Tek Ventures is backing this project that offers an optic solution to develop and monitor advanced therapies.
Makby: 3D bioprinting software for regenerative medicine
Basque Tek Ventures is backing this initiative that will revolutionise the field of artificial biological tissues.
Konbus+: Controlled temperature and high velocity thermal spray systems
The initiative, coming under Basque Tek Ventures, provides high value-added coatings in extreme conditions in a cost-effective manner.
K-ALMA: Generative AI for reliable software tests
Basque Tek Ventures is backing this project that automates the code validations by reducing their high certification cost.
INTELLIWELD: assessment of weld quality
Basque Tek Ventures supports this initiative offering an integrated system to analyse and control process and product in welding systems.
CRIOKEEP: device for the cryogenic storage, transport and dosing of therapeutic products
Basque Tek Ventures is backing this solution to improve the effectiveness of advanced medicine therapies by lowering risks and costs.
BATTBELT: mechanical management of batteries to improve their performance
The project, which is part of the Basque Tek Ventures initiative, helps to extend the life and energy density of lithium-ion batteries.
ORBIK: cybersecurity solutions for equipment with embedded electronics
Certification of technology products by means of assessing, detecting and monitoring their security vulnerabilities is the basis of this project hosted by the Basque Tek Ventures initiative.
OPTIDEL Biosystems: low liquefiable polyphenol solubilisation
The project, backed by the Basque Tek Ventures initiative, offers cosmetic-healthcare solutions to formulate more efficient topical products at a low cost.
NEWRO: stroke neurorehabilitation using robotic exoskeleton
The project, part of the Basque Tek Ventures initiative, will lead to therapies based on the hybrid brain-machine interface to recover after any degree of stroke.